Results 121 to 130 of about 631,189 (236)

FUNCTIONAL CONDITION OF THE MYOCARDIUM IN ACUTE CORONARY SYNDROME

Российский кардиологический журнал, 2001
The study included 127 patients with various courses of angina and was targeted at the evaluation of myocardial functional condition with the usage of Doppler echo and Holter monitoring.
A. N. Zakirova, R. G. Oganov, N. E. Zakirova   +2 more
doaj  

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Exercise-Induced Silent Myocardial Ischemia and Coronary Morbidity and Mortality in Middle-Aged Men

, 2020
OBJECTIVES We investigated the prognostic significance of exercise-induced silent myocardial ischemia in both high and low risk men with no prior coronary heart disease (CHD).
MD Tomi-Pekka Tuomainen, MD, PHD, MSC Rainer Rauramaa, MD Riitta Salonen, MD Timo A Lakka, Finland ‡ Kuopio, MD Jari A Laukkanen, MD Sudhir Kurl, MD Jukka T Salonen, MD Jaakko Eränen   +8 more
core  

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Diagnóstico de isquemia miocárdica silente en diabéticos tipo 2 mediante electrocardiograma, ergometría y Gated-SPECT Diagnosis of silent myocardial ischemia in type 2 diabetic patietns by electrocardiogram, ergometry and Gated-SPECT

Revista Cubana de Investigaciones Biomédicas, 2008
Para determinar la relación entre los factores de riesgos ateroscleróticos y la isquémica miocárdica silente fueron estudiados 31 pacientes diabéticos tipo 2 asintomáticos con exámenes de laboratorio, electrocardiograma, ergometría, Gated-SPECT y ...
Yamilé Peña Quián, José Fernández-Britto Rodríguez, Jorge Bacallao Gallestey, Juan Felipe Batista Cuéllar, Marco Antonio Coca Pérez, Noresma Toirac García, Andria Peña Coego   +6 more
doaj  

Cardiovascular outcome and home blood pressure in relation to silent myocardial ischemia in a clinical population: The J-HOP study. [PDF]

J Clin Hypertens (Greenwich), 2020
Shimizu H, Hoshide S, Kanegae H, Kario K.   +3 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Clinical effectiveness of long-term trimetazidine MB therapy in patients with cardio-respiratory disease (the results of an open, prospective multi-centre study)

Кардиоваскулярная терапия и профилактика, 2009
Aim. To study the prevalence and clinical features of cardio-respiratory disease (CRD): coronary heart disease (CHD) + chronic obstructive pulmonary disease (COPD). To assess the long-term effectiveness of a myocardial cytoprotector, trimetazidine MB, as
N. M. Kolomoets, V. I. Baksheev, E. G. Zarubina, K. U. Uvaysova, A. V. Pleshakov   +4 more
doaj  

Microalbuminuria (Moderate Albumin Excretion) and its relationship with Silent myocardial ischemia in treatment naïve type II diabetic patients. [PDF]

Pak J Med Sci, 2020
Hussain Q, Bukhari MH, Afzaal F, Fatima W.   +3 more
europepmc   +1 more source